Skip to main content

Table 3 Classification accuracy across visits

From: Short-term variability of Alzheimer’s disease plasma biomarkers in a mixed memory clinic cohort

 

Classification Accuracy (95% CI)

Biomarker

V1

V2

V3

Aβ40

0.68 (0.45, 0,86)

0.57 (0.34, 0.78)

0.65 (0.41, 0.85)

Aβ42

0.55 (0.32, 0.76)

0.52 (0.30, 0.74)

0.5 (0.27, 0.73)

Aβ42/Aβ40

0.55 (0.32, 0.76)

0.57 (0.34, 0.78)

0.5 (0.27, 0.73)

p-tau181

0.68 (0.45, 0.86)

0.71 (0.48, 0.89)

0.60 (0.36, 0.81)

p-tau217

0.68 (0.45, 0.86)

0.67 (0.43, 0.85)

0.75 (0.51, 0.91)

p-tau231

0.57 (0.34, 0.78)

0.52 (0.30, 0.74)

0.55 (0.32, 0.77)

T-tau

0.55 (0.32, 0.76)

0.5 (0.27, 0.73)

0.26 (0.09, 0.51)

NfL

0.32 (0.14, 0.55)

0.38 (0.18, 0.62)

0.5 (0.27, 0.73)

GFAP

0.59 (0.36, 0.80)

0.57 (0.34, 0.78)

0.55 (0.32, 0.77)

  1. Classification accuracy, based on a predictive classification model, together with their corresponding 95% CI
  2.  CI confidence interval, amyloid-β, p-tau phosphorylated tau, NfL neurofilament light, GFAP glial fibrillary acidic protein